The region’s world-leading medical technology research, which includes microwave technology and AI, and which is led by Chalmers together with Sahlgrenska University Hospital and Sahlgrenska Academy, is now taking big steps forward. The big news is that the solution for stroke detection, MD100 Strokefinder, which is owned by the Gothenburg company Medfield Diagnostics AB, received the long-awaited CE marking in June. The MD100 Strokefinder thus becomes the first market-approved and procurable product resulting from the regionally important research, which is based on strong local cooperation between experts in healthcare, academia and industry.
It is also new that the lab’s research groups have received grants of a total of SEK 15 million from the Swedish Research Council and the Swedish Armed Forces.
